Procurement Opportunity: Diclofenac Sodium Suppository 100 mg,Diclofenac Sodium SR 100 mg Tab,Chlorzoxazone 500 mg plus Acet

The eligibility requirements include the necessity for bidders to be a registered entity with proven experience in the medicinal products supply chain. Additionally, specific documents such as certification from the Original Equipment Manufacturer (OEM) and past performance reports must be provided to validate qualifications.

Bidders are mandated to submit various documentation, including an OEM Authorization Certificate, proof of past performance, financial turnover statements, and any other certificates as outlined in the tender documents. These certificates must demonstrate compliance with the technical specifications detailed in the BoQ.

The registration process requires interested parties to register on the official e-procurement site, ensure that all necessary documents are in place, and submit a detailed bid as per the guidelines provided in the tender documentation.

Bidders should submit documentation in PDF format unless otherwise specified in the tender notice. All files must be legible and properly indexed to facilitate the review process.

Bidders will need to adhere to the technical specifications grounded in the provided Bill of Quantities. This includes compliance with quality standards outlined in the tender documents, ensuring that the supplied products meet outlined health regulations and safety assessment guidelines.

Quality standards requisite for this tender call for compliance with industry-established norms for pharmaceutical products. Successful bidders must showcase ongoing quality assurance and quality control measures, affording priority to certified suppliers.

Compliance requirements necessitate strict adherence to the specifications in the BoQ and all pertinent regulations governing the procurement of medical supplies. A detailed checklist outlining compliance conditions is made available in the tender documentation.

Testing criteria for the products require verification that goods conform to the specifications established in the tender documentation. Any deviations must be met with documented justifications and, where applicable, alternative provisions for compliance.

The Earnest Money Deposit (EMD) stipulated for this tender is 117. This amount is necessary to validate each bidder’s commitment to the bidding process and must be submitted along with their bid to be considered.

Bidders awarded contracts will be required to furnish a performance security as stipulated in the tender documentation, ensuring that contractual obligations will be met satisfactorily throughout the procurement lifecycle.

Payment terms are established based on the delivery milestones met by the supplier. The exact terms will be detailed in the bid acceptance notice, ensuring they align with industry standards for pharmaceutical acquisition.

The price evaluation will focus on the item-wise cost, ensuring that the lowest priced bid that meets all technical specifications will be prioritized for selection. Any additional costs will be factored into the overall assessment.

Bidders must submit their bids electronically through the designated e-procurement platform. Submissions should include all required documentation as specified in the tender guidelines to ensure validity.

Key timelines, including the bid submission deadline and opening dates, are specified in the tender documents. It is essential for bidders to adhere to these deadlines to guarantee consideration in the procurement process.

The evaluation process will involve a detailed analysis of submitted bids based on technical compliance, financial standing, and the demonstrated capability to fulfill the requirements. Bidders will receive notifications regarding their evaluation results in a timely manner.

The tender includes specific provisions aimed at supporting Micro, Small, and Medium Enterprises (MSEs) and startups, permitting exemptions from specific experience criteria, thereby promoting inclusivity and broader participation in the procurement process.

This tender promotes compliance with 'Make in India' initiatives by prioritizing local sourcing of materials and encouraging adherence to local production norms, thus bolstering domestic capabilities and fostering local employment.

Bidders must comply with local content and procurement rules set forth in the tender documentation, emphasizing the use of domestically manufactured goods and components to stimulate local industry growth and resilience.